Since IL-22 administration has a positive impact on survival in murine GvHD (11, 12), we tested the hypothesis that IL22 expression might have an impact on transplant-related mortality (TRM) and therefore separated the patients in regard to both, GvHD and TRM. This evidence concerns the gene IL22 and graft versus host disease.